{"id":5459,"date":"2022-12-14T12:52:42","date_gmt":"2022-12-14T12:52:42","guid":{"rendered":"https:\/\/preprod.treefrog.fr\/?p=5459"},"modified":"2022-12-22T09:06:16","modified_gmt":"2022-12-22T09:06:16","slug":"2023-treefrogs-wishes","status":"publish","type":"post","link":"https:\/\/preprod.treefrog.fr\/2023-treefrogs-wishes\/","title":{"rendered":"2023 TreeFrog’s wishes"},"content":{"rendered":"\t\t
110+ Froggies across France, USA and Japan wish you a Merry Christmas and all the best for 2023 !<\/strong><\/p>\n<\/strong> <\/strong><\/p>\n 2 years ago, we announced we would have a GMP-grade encapsulation device by the end of 2022. Here we are ! Right on time!<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t This collaboraion with US-based biotech\u00a0Umoja Biopharma<\/a>\u00a0aims at leveraging the C-Stem\u2122 platform for the large-scale amplification and immune differentiation of Umoja’s iPS cell line edited with the RACR\u2122 technology.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t In October, we were glad to award the $100,000 Stem Cell SpaceShot Grant<\/a> to a team working on the reprogramming of iPS-derived macrophages for neuronal repair.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t We added industry insiders to our Board in 2022: Elsy Boglioli, Chair of the Board (formerly Cellectis),\u00a0Melissa Carpenter, PhD (Elevate Bio) and Peter Nell, PhD (formerly Bayer, Mammoth Biosciences, Casebia).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t In March 2022, TreeFrog announced the formation of its scientific advisory board, with a strong bias for interdisciplinarity.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t In October, co-founder K\u00e9vin Alessandri moved to Boston to lead our technological hub at Lab Central 238<\/a> (Cambridge-Kendall Square, MA, USA). In Japan, our team is currently setting up the lab at the Creative Lab for Innovation in Kobe (CLIK). What happened in 2022 at TreeFrog?<\/b><\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Moving to GMP manufacturing<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
First collaboration in immuno-oncology <\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
$100,000 to 3 PhD students from King’s College London<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
3 new independent board members<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Word-class scientific advisors in physics, stem cells & gene editing<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Opening hubs in Kobe and Boston<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Why hubs ? <\/b>To showcase our technology and build local partnerships. Curious? Come and visit us!<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t